Dale Wright

Dale Wright is a Drug Discovery and Portfolio Strategy Leader focused on the development of small molecule and antibody therapeutics for inflammation. With a Ph.D. in Immunology from Kansas State University, they have held significant roles in pharmaceutical research, including positions at Mallinckrodt Pharmaceuticals, Covance, Array BioPharma, and UCB Pharma, where they led initiatives in inflammation pharmacology. Currently, Dale serves as the Executive Director of Inflammation & Systems Biology at Inotiv and has played a pivotal role in advancing drug discovery programs at Serna Bio. Their expertise spans various disease indications and project leadership across the R&D process, from high-throughput screening to clinical development support.